Search research articles
Contact Us
Filters
Showing results (1-10 of 65) with videos related to
Page
of 7
Sort By:
Diabetes Technology & Therapeutics
|
February 19, 2020
Where Do We Stand with Closed-Loop Systems and Their Challenges?
Melanie Jackson, Jessica R Castle
Journal of Diabetes Science and Technology
|
February 20, 2010
Amperometric glucose sensors: sources of error and potential benefit of redundancy
Jessica R Castle, W Kenneth Ward
Journal of Diabetes Science and Technology
|
February 9, 2018
Stable Liquid Glucagon: Beyond Emergency Hypoglycemia Rescue
Leah M Wilson, Jessica R Castle
Diabetes Technology & Therapeutics
|
April 21, 2020
Recent Advances in Insulin Therapy
Leah M Wilson, Jessica R Castle
Journal of Diabetes Science and Technology
|
February 17, 2016
Nonadjunctive Use of Continuous Glucose Monitoring for Diabetes Treatment Decisions
Jessica R Castle, Peter G Jacobs
Diabetes Technology & Therapeutics
|
June 7, 2017
Future of Automated Insulin Delivery Systems
Jessica R Castle, J Hans DeVries, Boris Kovatchev
Journal of Diabetes Science and Technology
|
January 10, 2012
Safe glycemic management during closed-loop treatment of type 1 diabetes: the role of glucagon, use of multiple sensors, and compensation for stress hyperglycemia
W Kenneth Ward, Jessica R Castle, Joseph El Youssef
Endocrinology and Metabolism Clinics of North America
|
January 26, 2020
Role of Glucagon in Automated Insulin Delivery
Leah M Wilson, Peter G Jacobs, Jessica R Castle
Diabetes Technology & Therapeutics
|
January 10, 2020
Reliability of the Dexcom G6 Continuous Glucose Monitor During Hyperbaric Oxygen Exposure
Enoch Huang, Shaban Demirel, Chanelle Bliss, et al.
Journal of Diabetes Science and Technology
|
May 31, 2014
Can glucose be monitored accurately at the site of subcutaneous insulin delivery?
W Kenneth Ward, Jessica R Castle, Peter G Jacobs, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 65) with videos related to
Sort By:
Page
of 7
Diabetes Technology & Therapeutics
|
February 19, 2020
Where Do We Stand with Closed-Loop Systems and Their Challenges?
Melanie Jackson, Jessica R Castle
Journal of Diabetes Science and Technology
|
February 20, 2010
Amperometric glucose sensors: sources of error and potential benefit of redundancy
Jessica R Castle, W Kenneth Ward
Journal of Diabetes Science and Technology
|
February 9, 2018
Stable Liquid Glucagon: Beyond Emergency Hypoglycemia Rescue
Leah M Wilson, Jessica R Castle
Diabetes Technology & Therapeutics
|
April 21, 2020
Recent Advances in Insulin Therapy
Leah M Wilson, Jessica R Castle
Journal of Diabetes Science and Technology
|
February 17, 2016
Nonadjunctive Use of Continuous Glucose Monitoring for Diabetes Treatment Decisions
Jessica R Castle, Peter G Jacobs
Diabetes Technology & Therapeutics
|
June 7, 2017
Future of Automated Insulin Delivery Systems
Jessica R Castle, J Hans DeVries, Boris Kovatchev
Journal of Diabetes Science and Technology
|
January 10, 2012
Safe glycemic management during closed-loop treatment of type 1 diabetes: the role of glucagon, use of multiple sensors, and compensation for stress hyperglycemia
W Kenneth Ward, Jessica R Castle, Joseph El Youssef
Endocrinology and Metabolism Clinics of North America
|
January 26, 2020
Role of Glucagon in Automated Insulin Delivery
Leah M Wilson, Peter G Jacobs, Jessica R Castle
Diabetes Technology & Therapeutics
|
January 10, 2020
Reliability of the Dexcom G6 Continuous Glucose Monitor During Hyperbaric Oxygen Exposure
Enoch Huang, Shaban Demirel, Chanelle Bliss, et al.
Journal of Diabetes Science and Technology
|
May 31, 2014
Can glucose be monitored accurately at the site of subcutaneous insulin delivery?
W Kenneth Ward, Jessica R Castle, Peter G Jacobs, et al.
Page
of 7